<?xml version="1.0" encoding="UTF-8"?>
<p>Apoptosis, a form of programmed cell death takes place in multicellular organisms, is a series of biochemical events that result in characteristic cell changes and death
 <xref rid="CIT0017" ref-type="bibr">
  <sup>17</sup>
 </xref>. Apoptosis could be launched through one of two pathways (intrinsic pathway and extrinsic pathway). The mitochondria-dependent apoptotic pathway (intrinsic pathway), one of the main pathways of induction of the cell apoptosis
 <xref rid="CIT0018" ref-type="bibr">
  <sup>18</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0019" ref-type="bibr">
  <sup>19</sup>
 </xref>, is controlled by the Bcl2 proteins family. The Bcl2 family members have dual functions; some are anti-apoptotic Bcl2 proteins, such as Bcl2 and BclxL that inhibit apoptosis, while others are pro-apoptotic Bcl2 proteins such as Bax and Bak that promote apoptosis
 <xref rid="CIT0014" ref-type="bibr">
  <sup>14</sup>
 </xref>. In this regard, it was reported that most of cancer cells are characterised by over-expression of the anti-apoptotic Bcl2 proteins which could lead to apoptosis prevention as well as drug resistance
 <xref rid="CIT0020" ref-type="bibr">
  <sup>20</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0021" ref-type="bibr">
  <sup>21</sup>
 </xref>. Thus, the development of anti-apoptotic Bcl2 proteins inhibitors has become an important strategy for introducing potential anti-cancer agents
 <xref rid="CIT0015" ref-type="bibr">
  <sup>15</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0016" ref-type="bibr">
  <sup>16</sup>
 </xref>. In this manner, several heterocyclic scaffolds including isatin
 <xref rid="CIT0022" ref-type="bibr">
  <sup>22</sup>
 </xref> were developed as candidates targeting Bcl2 proteins.
</p>
